Kummerfeld Keith C's Form 4 filing
Arcturus Therapeutics Holdings Inc. (ARCT) · filed Apr 19, 2023
- Accession no.
- 0001193805-23-000578
- Filed
- Apr 19, 2023
- Trade date
- Apr 17-18, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 3 derivative transactions. Open-market sales total $196.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kummerfeld Keith CCIK 0001762749 | Officer (See Remarks) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 18, 2023 | Common Stock | MOption exerciseAcquired | +1,031 | $14.12 | +$14,557.72 | 1,981 | Direct | |
| Apr 18, 2023 | Common Stock | MOption exerciseAcquired | +4,500 | $9.04 | +$40,680 | 6,481 | Direct | |
| Apr 18, 2023 | Common Stock | MOption exerciseAcquired | +1,437 | $4.99 | +$7,170.63 | 7,918 | Direct | |
| Apr 18, 2023 | Common Stock | SSaleDisposed | −6,968 | $28.18F2 | −$196,358.24 | 950 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 17, 2023 | Common Stock | MOption exerciseDisposed | −1,031 | $0.00 | $0 | 8,969 | Direct | |
| Apr 17, 2023 | Common Stock | MOption exerciseDisposed | −4,500 | $0.00 | $0 | 25,500 | Direct | |
| Apr 17, 2023 | Common Stock | MOption exerciseDisposed | −1,437 | $0.00 | $0 | 8,563 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.62 to $28.57 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold by it at each separate price on April 17, 2023.
Referenced by the price of 1 transaction in Table I.
Remarks
Senior Vice President of Finance (Principal Accounting Officer)